CervoMed announced pharmacokinetic and regulatory updates for its lead drug candidate, neflamapimod, including a new 50 mg oral tablet formulation and the FDA's removal of a previous drug exposure limit. These developments allow the company to advance a 100 mg twice-daily dosing regimen in future clinical trials, which is expected to achieve higher drug concentrations and improve patient convenience compared to prior three-times-daily dosing.
NeOnc Technologies has scheduled an in-person End-of-Phase 1 Type B meeting with the FDA for November 17, 2026, to discuss the clinical development of NEO212. The company intends to seek feedback on Phase 2 study design, patient populations, and potential accelerated approval pathways following encouraging Phase 1 results in glioblastoma and brain metastases.
San Juan Basin Royalty Trust provided an operational update regarding administrative expenses and the conclusion of a 2017–2020 joint interest audit. The Trustee reported a $976,000 year-over-year decrease in G&A expenses following the transition to Argent Trust Company and determined that pursuing further recovery from the Hilcorp audit was not cost-effective.
M&T Bank Corporation is implementing changes and reclassifications to its financial statement presentation effective for the third quarter of 2026, including updates to 'Other income' categories and the separate presentation of loans held for sale. The company provided unaudited supplemental historical financial information to conform prior periods to this new presentation, noting that these changes have no impact on total net income or earnings per share.
Oncolytics Biotech provided an operational update on its REO 033 randomized study for colorectal cancer, noting that substantially all clinical sites are now activated and enrollment is accelerating. The company expects to report interim clinical data from Part A of the study by year-end 2026 and has aligned with the FDA on a potential registration path for accelerated approval.
Brookfield Asset Management is revising its presentation of non-GAAP financial measures, including Fee Revenues and Fee-Bearing Capital, to provide more detail on its partner managers. The company provided recast historical data for the past eight quarters to assist analysts in modeling, though the changes do not impact previously reported Fee-Related Earnings or Distributable Earnings.
Bitmine Immersion Technologies provided an operational update disclosing that its total crypto, cash, and marketable securities holdings have reached $17.2 billion. The company now holds over 6 million ETH tokens, representing approximately 4.9% of the total ETH supply, and reported that its institutional-grade staking platform MAVAN currently has 5,067,309 staked ETH.
Greenland Energy Company successfully completed its 2026 environmental baseline field program at the Jameson Land Project in East Greenland. The program, which included soil sampling and wildlife studies, is a required regulatory step to support the Environmental Impact Assessment (EIA) and permitting process for future exploration drilling.
DeFi Development Corp. reported a 2% weekly increase in its Solana (SOL) treasury holdings, reaching a total of 2,538,010 SOL and SOL equivalents valued at approximately $309 million. The company has grown its SOL treasury by 10% since its August 12 earnings update and intends to deploy these assets through staking and validator infrastructure to support its 'Digital Credit 2.0' strategy.
Fate Therapeutics was awarded a $15 million CLIN2 grant from the California Institute for Regenerative Medicine (CIRM) to support its Phase 2 RECLAIM-LN clinical trial. The funding will advance the development of FT819, an off-the-shelf CAR T-cell therapy for patients with refractory lupus nephritis, a severe manifestation of systemic lupus erythematosus.
Counterparty
California Institute for Regenerative Medicine (CIRM)
Strive, Inc. provided an operational update disclosing the purchase of 1,107 bitcoin between September 21 and September 25, 2026, at an average price of $85,396 per token. The company also reported updated treasury holdings, showing a total of 27,462 bitcoin and $248.8 million in cash and cash equivalents as of September 25, 2026.
Flutter Entertainment has ceased its sports betting and iGaming operations in Brazil following a provisional executive order from the Brazilian Government banning such activities. The company expects this cessation to reduce its 2026 revenue by approximately $70 million and adjusted EBITDA by $20 million if operations remain suspended for the rest of the year.
U.S. GoldMining Inc. announced the completion of its 2026 surface exploration program at the Whistler Gold-Copper Project in Alaska, which included geological mapping and rock chip sampling. The program identified new outcrop zones of gold-copper porphyry-style mineralization and expanded the target pipeline at the Whistler Orbit, Island Mountain, and Muddy Creek areas. Assay results for 58 rock grab samples are currently pending as the company works to delineate high-priority targets for future drill testing.
Microbot Medical Inc. disseminated a press release on September 25, 2026, providing an update on its growth strategies. The filing was made under Item 7.01 (Regulation FD Disclosure) to communicate strategic developments to investors.
KLX Energy Services updated its Q3 2026 guidance, narrowing its revenue range to $180-$185 million and projecting a 200 basis point sequential improvement in Adjusted EBITDA margin. The company also announced the expiration of its $125 million subscription rights offering, which management described as a transformational step for deleveraging and future growth.
Morningstar released its periodic Investor Q&A, providing management's responses to shareholder questions regarding M&A strategy and board refreshment. The company reaffirmed its capital allocation priorities, including organic investment, opportunistic share repurchases, and dividend growth, while noting the recent appointment of Anne Bramman to the board.
Graphene & Solar Technologies' subsidiary, QSM USA, received approval for a $15 million Sales and Use Tax Exclusion from CAEATFA for its planned California manufacturing operations. The incentive applies to up to $176.5 million in equipment purchases and is intended to improve capital efficiency for the company's 10-gigawatt silicon wafer production facility.
Counterparty
California Alternative Energy and Advanced Transportation Financing Authority (CAEATFA)
Astrotech Corporation reported its fiscal year 2026 operational highlights, including the deployment of its TRACER 1000 in 37 locations globally and the launch of its Labrador ruggedized handheld gas chromatograph. The company also announced a new strategic initiative through its subsidiary, Lunar Power and Light Corporation, focused on developing industrial infrastructure and semiconductor processing capabilities on the lunar surface.
NexPoint Capital, Inc. announced that its net asset value (NAV) per share was determined to be $4.64 as of September 22, 2026. This figure also serves as the price at which the company will issue shares under its distribution reinvestment plan (DRP).
Ellington Financial Inc. announced an estimated book value per share of common stock of $13.62 as of August 31, 2026. This estimate includes the impact of a previously announced monthly dividend of $0.13 per share payable on September 30, 2026.
Stifel Financial Corp. reported selected operating results for August 31, 2026, highlighting record total client assets of $587.6 billion and fee-based client assets of $244.4 billion. The company noted a 7% month-over-month increase in treasury deposits and provided a third-quarter revenue outlook, expecting firm-wide net revenue to be essentially flat compared to the prior year.
MetLife provided a preliminary estimate for its Q3 2026 variable investment income, expecting it to be at least $600 million (pre-tax). This figure is being disclosed ahead of the formal quarterly earnings release scheduled for November 4, 2026, and is compared against the company's full-year 2026 guidance of approximately $1.6 billion.
Teucrium Commodity Trust announced that its 7RCC Spot Bitcoin and Carbon Credit Futures ETF (BTCK) has resumed accepting redemption orders after the number of outstanding shares rose above the 50,000-share minimum threshold. The Sponsor had previously been rejecting redemptions to maintain minimum share levels, but new creation orders have now increased the fund's size above that limit.
Aptevo Therapeutics announced operational progress in its next-generation trispecific cancer programs, specifically focusing on optimizing manufacturing scalability for its lead candidate, APVO451. The company expects to initiate Investigational New Drug (IND) enabling studies for APVO451 in the first half of 2027. This update signals the transition of the trispecific platform from molecular design toward clinical development readiness.
Sky Quarry Inc. has received an air permit from the Nevada Division of Environmental Protection and restarted operations at its Eagle Springs Refinery near Ely, Nevada. The company completed $300,000 in repairs and upgrades to the facility, which has a nameplate capacity of 5,000 barrels of crude oil per day. The restart allows the company to begin ramping up production of Nevada-refined products to serve the regional market.
aTyr Pharma reached alignment with the FDA on the protocol for a new Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary sarcoidosis with restrictive lung disease. The global study is expected to enroll approximately 372 patients and initiate study-related activities in the fourth quarter of 2026.
Cullinan Therapeutics outlined its anticipated pipeline milestones for the fourth quarter of 2026, including data readouts for its T cell engager programs CLN-978, velinotamig, and CLN-049. The company plans to share multi-dose regimen data for CLN-978 across SLE, RA, and Sjögren’s disease in December, and velinotamig data at the ACR Convergence conference in November.
Artificial Intelligence Technology Solutions Business Update
Artificial Intelligence Technology Solutions (AITX) announced a hardware price increase for its Robotic Assistance Devices (RAD) security solutions to offset rising material, compute, and transportation costs. Channel partner pricing for ROSA and AVA units increased by approximately 6%, with higher adjustments for the steel-intensive RIO solar-powered platforms, while ROAMEO pricing remains unchanged.
NexMetals Mining Corp. reported high-grade assay results from its ongoing surface drilling program at the Selebi Main deposit in Botswana, including 7.55 metres grading 6.48% CuEq. The results, along with a new visual intercept in drill hole SMD-26-217, extend the high-grade trend to approximately 1.5 kilometres and identified a new third zone of massive sulphide mineralization. These findings support the company's exploration model and indicate significant potential for resource growth beyond the current 2024 Mineral Resource Estimate.
First Breach Inc. successfully completed the first untethered flight of its proprietary drone prototype, validating the airframe and propulsion systems. The company is developing its own flight controller in partnership with Hellbender and remains on track to complete initial prototypes in Q4 2026 with production scaling targeted for Q2 2027.